Form 4: Kiniksa Pharmaceuticals International Director Sells Shares
Insider Transaction (Form 4)
G Bradley Cole, a Director of Kiniksa Pharmaceuticals International, plc, sold 3,673 shares of common stock on July 29, 2026 for $81.43 per share.
Summary
- Open-market sale: disposed of 3,673 Class A Ordinary Share at $81.43 ($299,092) on July 29, 2026; holds 11,672 after (Direct).
- Bona fide gift: disposed of 4,500 Class A Ordinary Share on July 29, 2026; holds 7,172 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $299,092 of stock on the open market.
Insider Transactions
G Bradley Cole — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-29 | Open-market sale | Class A Ordinary Share | 3,673 | $81 | $299.1K | 11,672 |
| 2026-07-29 | Bona fide gift | Class A Ordinary Share | 4,500 | — | — | 7,172 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-29 | Open-market sale (3,673 shares) |
| 2026-07-29 | Bona fide gift (4,500 shares) |
Keywords
insider transaction, Form 4, KNSA, Kiniksa Pharmaceuticals International, plc, bearish, G Bradley Cole
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.